Stanoplex 10 mg is an oral stanozolol product manufactured by Axiolabs and supplied as 10 mg tablets in a 10-tablet package.
Stanoplex 10 mg contains stanozolol, a synthetic 17-alpha-alkylated anabolic-androgenic steroid derived from dihydrotestosterone. Stanozolol is structurally characterized by a pyrazole ring fused to the A-ring of the steroid nucleus, a modification that confers oral bioavailability and resistance to hepatic breakdown. Its anabolic activity is mediated through binding to androgen receptors, including membrane-bound receptor proteins LAGS and the stanozolol-binding protein (STBP).
In clinical medicine, stanozolol has been approved for the treatment of hereditary angioedema and has been investigated for conditions including anemia, osteoporosis, and inflammatory disorders. The FDA-approved Winstrol (stanozolol) tablet product is currently listed as discontinued in the Orange Book. In non-medical bodybuilding contexts, stanozolol is commonly referenced during cutting phases due to its reputation for producing hard, dry muscle appearance with minimal water retention. It does not aromatize to estrogen, which distinguishes it from testosterone-based compounds.
Stanozolol's effects include increased protein synthesis and nitrogen retention, though its practical profile in bodybuilding is often described as promoting hardness and vascularity rather than large mass gains. It is also associated with joint dryness, which can increase injury risk. Non-medical use of stanozolol falls outside approved medical indications and carries significant hepatic and cardiovascular risks.
Stanozolol is a 17-alpha-alkylated oral anabolic steroid with a distinctive pyrazole structure, known for producing hard, dry muscle appearance and for its hepatic and joint-related considerations.
Stanozolol's structure features a pyrazole ring fused to the A-ring, a modification that distinguishes it from other oral anabolic steroids and contributes to its oral bioavailability. The 17-alpha-alkylation protects the molecule from first-pass hepatic metabolism, but this same structural feature places stanozolol in the class associated with hepatotoxicity.
Stanozolol has a biological half-life of approximately 24 hours according to PubChem data. It does not undergo aromatization or 5-alpha reduction, meaning it does not convert to estrogen and is not amplified by 5-alpha reductase in tissues like the prostate or scalp. This contributes to its reputation as a "dry" compound with minimal water retention.
The compound is metabolized extensively, with urinary metabolites including 3'-hydroxystanozolol, 4β-hydroxystanozolol, and 16α/β-hydroxystanozolol. These metabolites are detectable for weeks after administration, which is relevant in anti-doping contexts.
Stanozolol's inability to aromatize and its tendency to cause joint dryness define much of its practical profile. It is commonly referenced for hardening effects but is also associated with increased tendon injury risk.
Axiolabs produces several oral anabolic products that are referenced in different contexts. Stanoplex 10 mg is a stanozolol product, placing it among the harder, drier oral options compared to compounds like Methanoplex (methandienone), which is more commonly associated with mass-building and water retention.
For bodybuilders seeking a milder oral alternative, Oxandroplex (oxandrolone) is frequently referenced for cutting phases with less joint-related discomfort. For those considering injectable options for cutting, Mastaplex 100 (drostanolone propionate) is commonly discussed. The choice between these compounds depends on individual goals, tolerance for joint dryness, and hepatic considerations.
The information below is provided for educational reference only. Stanozolol is a prescription medication in many jurisdictions; medical use requires appropriate diagnosis and clinical supervision. Non-medical use falls outside approved indications.
In non-medical bodybuilding contexts, oral stanozolol is commonly referenced in the range of 25–50 mg per day for men, typically split into two or three doses due to the compound's short half-life. Some experienced users reference higher totals of 75–100 mg/day, but the 25–50 mg/day range represents the most frequently discussed window. Women are generally referenced at 5–10 mg per day, with careful attention to virilization signs.
| Use Case | Common Reference Range | Frequency |
|---|---|---|
| Bodybuilding (men, non-medical) | 25–50 mg / day | Split into 2–3 doses |
| Bodybuilding (women, non-medical) | 5–10 mg / day | Once daily or split |
| Advanced (non-medical) | 75–100 mg / day | 2–3 divided doses |
Stanozolol is frequently referenced as a finishing compound in cutting cycles rather than as a standalone base. In non-medical contexts, it is sometimes combined with injectable compounds such as Testaplex P 100 or Trenaplex A 100 during the final weeks of a cycle. Cycle duration in non-medical discussions is commonly limited to 4–6 weeks due to hepatic considerations associated with 17-alpha-alkylated compounds.
Joint dryness and associated tendon pain are commonly reported with stanozolol use, particularly at higher doses and in individuals with pre-existing joint issues. This effect is sometimes managed by reducing training intensity or avoiding maximal lifts during the cycle. Blood lipid monitoring is relevant as stanozolol can significantly reduce HDL cholesterol.
Liver support supplementation is commonly referenced during oral anabolic use. Bloodwork monitoring for hepatic markers is particularly important given stanozolol's 17-alpha-alkylated structure. Stanozolol should not be stacked with other 17-alpha-alkylated oral compounds due to additive hepatotoxicity risk.
Stanozolol suppresses endogenous testosterone production, and post-cycle therapy is commonly recommended after a cycle. Agents such as Clomiplex and Tamoxiplex are frequently referenced for this purpose. Stanozolol itself clears relatively quickly from the system, but PCT timing should account for the ester clearance of any long-acting injectables used in the same cycle.
Dosing strategies and support protocols should account for individual experience and health status. The information above is for educational reference and does not constitute medical advice.
Stanozolol is a 17-alpha-alkylated anabolic steroid with significant hepatic and cardiovascular considerations. Medical use requires appropriate diagnosis and ongoing clinical supervision.
Stanozolol is a C17-alpha-alkylated anabolic steroid, a class associated with hepatotoxicity. Documented hepatic effects include elevated liver enzymes, cholestatic jaundice, and in rare cases hepatic adenoma and peliosis hepatis. These risks increase with dose, duration, and concurrent use of other hepatotoxic compounds.
Stanozolol can significantly reduce HDL cholesterol and may increase LDL cholesterol, contributing to an unfavorable lipid profile. This is particularly relevant for individuals with existing cardiovascular risk factors.
Stanozolol is not approved for bodybuilding or athletic performance enhancement. Non-medical use falls outside approved indications and may carry additional health risks beyond those associated with supervised medical use.
Hepatic effects are a primary concern. Cholestatic jaundice, hepatic adenoma, and peliosis hepatis have been documented with stanozolol use. Liver function monitoring is essential during medical use.
Joint dryness and tendon pain are commonly reported, with increased risk of tendon rupture at high doses or when training through pain. This risk is specifically associated with the compound's drying effects and is clustered at triceps, pectoral, and quadriceps tendons.
Androgenic effects can include acne, scalp hair loss, and increased body hair. In women, virilization signs including voice deepening and clitoral enlargement may be irreversible. Stanozolol suppresses endogenous testosterone production and can reduce sperm production and testicular weight, as demonstrated in animal studies.
Cardiovascular effects may include significant HDL reduction and blood pressure elevation.
Stanozolol is contraindicated in pregnancy and in patients with known or suspected prostate or male breast cancer. Caution is advised in individuals with pre-existing hepatic disease, cardiovascular conditions, or lipid disorders. Medical evaluation is required before any consideration of therapeutic use.
Medically supervised stanozolol therapy typically involves periodic liver function testing and lipid monitoring. These monitoring practices are relevant to medical use; non-medical use lacks the same clinical oversight. Blood pressure should also be monitored given the potential for elevation.
Store tablets in a cool, dry place away from direct light and moisture. Keep in original packaging until use. Keep out of reach of children. Do not use if the product appears damaged or compromised.
Stanoplex 10 mg is shipped in original manufacturer packaging with discreet, privacy-focused handling.
Outer packaging remains discreet with no external product details. Products are supplied in original manufacturer presentation.
To verify product authenticity, examine the packaging for manufacturer security features and compare against official Axiolabs presentation. Original packaging and consistent labeling help confirm product legitimacy.
For complete delivery details, please see our Shipping Info page.
Proper storage conditions help preserve product integrity and tablet stability.
Store in a cool, dry place at controlled room temperature. Protect from excessive heat, moisture, and direct light. Keep tablets in their original packaging until use. Do not use if the product appears compromised or if tablets show signs of deterioration.
Keep out of reach of children. Follow proper handling practices.
Answers to common questions about Stanoplex 10 mg, stanozolol, dosing, and product characteristics.
Stanoplex 10 mg contains stanozolol, an oral anabolic steroid. In medical practice, stanozolol has been used for hereditary angioedema and investigated for other conditions. In non-medical bodybuilding contexts, it is commonly referenced during cutting phases for muscle hardening and vascularity. Non-medical use falls outside approved indications.
Stanozolol has a biological half-life of approximately 24 hours according to PubChem data. In bodybuilding contexts, it is typically referenced as being taken in 2–3 divided doses per day due to its short half-life. This is distinct from medically supervised dosing, which is individualized by a clinician.
In non-medical bodybuilding contexts, post-cycle therapy is commonly recommended after a stanozolol cycle to support recovery of endogenous testosterone production. Agents such as Clomiplex or Tamoxiplex are commonly referenced for this purpose. Stanozolol suppresses natural testosterone production.
Stanozolol binds to androgen receptors and stimulates anabolic activity, promoting nitrogen retention and protein synthesis. It does not aromatize to estrogen, which contributes to its "dry" profile. In bodybuilding contexts, it is primarily valued for muscle hardening effects rather than large mass gains.
In bodybuilding discussions, users sometimes report noticeable hardening and vascularity effects within the first 1–2 weeks of use at 25–50 mg/day. Individual response varies, and these timelines are based on non-medical user reports rather than controlled clinical data for this specific use case.
There is no universally "best" oral steroid for cutting. Stanozolol is commonly referenced for its hardening effects, but it is associated with joint dryness and hepatic considerations. Other compounds such as Oxandroplex (oxandrolone) are also referenced for cutting with different side effect profiles. The appropriate choice depends on individual goals and tolerances.
Both are oral 17-alpha-alkylated anabolic steroids, but they have different profiles. Stanozolol is often described as producing harder, drier muscle with more joint dryness, while oxandrolone is generally considered milder with less joint impact. Axiolabs offers Oxandroplex as its oxandrolone product.
Stanozolol and methandienone are both oral 17-alpha-alkylated steroids, but stanozolol is a non-aromatizing DHT derivative while methandienone aromatizes to estrogen. Stanozolol is typically referenced for cutting, while methandienone is more commonly associated with bulking. Axiolabs offers Methanoplex as its methandienone product.
In bodybuilding contexts, 50 mg per day is at the upper end of commonly referenced ranges for men, with 25 mg/day being a more moderate starting point. Stanoplex 10 mg contains 10 mg per tablet, so 50 mg would equal five tablets daily. Dosage appropriateness depends on individual factors and the overall cycle context.
Stanoplex 10 mg is supplied as 10 mg stanozolol tablets in a 10-tablet package, giving 100 mg of total labeled stanozolol content.
Stanozolol is sometimes referenced in bodybuilding contexts for women at low doses of 5–10 mg/day due to its non-aromatizing profile. However, androgenic effects including voice deepening and clitoral enlargement are possible and may be irreversible. Women should be aware of these risks and stop at the first sign of virilization.
Stanozolol is a 17-alpha-alkylated anabolic steroid and is associated with hepatic effects including elevated liver enzymes and, in rare cases, cholestatic jaundice and hepatic adenoma. Liver function monitoring is part of medically supervised use. Stanozolol should not be stacked with other 17-alpha-alkylated oral compounds.